1. Home
  2. RDY vs AKR Comparison

RDY vs AKR Comparison

Compare RDY & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • AKR
  • Stock Information
  • Founded
  • RDY 1984
  • AKR 1993
  • Country
  • RDY India
  • AKR United States
  • Employees
  • RDY N/A
  • AKR N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • AKR Real Estate Investment Trusts
  • Sector
  • RDY Health Care
  • AKR Real Estate
  • Exchange
  • RDY Nasdaq
  • AKR Nasdaq
  • Market Cap
  • RDY 2.1B
  • AKR 2.1B
  • IPO Year
  • RDY N/A
  • AKR 1993
  • Fundamental
  • Price
  • RDY $13.24
  • AKR $19.54
  • Analyst Decision
  • RDY Buy
  • AKR Buy
  • Analyst Count
  • RDY 1
  • AKR 4
  • Target Price
  • RDY $17.00
  • AKR $22.00
  • AVG Volume (30 Days)
  • RDY 1.9M
  • AKR 1.3M
  • Earning Date
  • RDY 05-06-2025
  • AKR 04-29-2025
  • Dividend Yield
  • RDY 3.61%
  • AKR 3.80%
  • EPS Growth
  • RDY 2.68
  • AKR N/A
  • EPS
  • RDY 0.75
  • AKR 0.19
  • Revenue
  • RDY $3,637,607,642.00
  • AKR $375,840,000.00
  • Revenue This Year
  • RDY $17.23
  • AKR N/A
  • Revenue Next Year
  • RDY $9.19
  • AKR $21.72
  • P/E Ratio
  • RDY $17.94
  • AKR $105.79
  • Revenue Growth
  • RDY 14.74
  • AKR 13.20
  • 52 Week Low
  • RDY $12.50
  • AKR $16.14
  • 52 Week High
  • RDY $16.89
  • AKR $26.29
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • AKR 33.67
  • Support Level
  • RDY $13.09
  • AKR $20.35
  • Resistance Level
  • RDY $13.85
  • AKR $21.26
  • Average True Range (ATR)
  • RDY 0.14
  • AKR 0.44
  • MACD
  • RDY 0.02
  • AKR -0.02
  • Stochastic Oscillator
  • RDY 19.74
  • AKR 2.43

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company's portfolios are located primarily in metropolitan areas of the United States. The company operates through three segments: core portfolio, which consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon and generates the majority of total revenue; funds, which comprises the funds launched by the trust; and structured financing, which consists of notes receivable and related interest income.

Share on Social Networks: